Highlights of Ending Age-Related Diseases 2020
Key points from 20 presentations from world-leading researchers
Join the club for FREE to access the whole archive and other member benefits.
Co-Founder CEO at Rubedo Life Sciences
Following a Masters degree in Biotechnology, a PhD in Neuroscience, and post-doctoral training in Stem Cells and Regenerative Medicine, he then led a team at Stanford University focused on translational medical research in the Department of Neurology and Neurological Sciences. Previously, he did a post doc at Stanford with his mentor, Prof. Thomas Rando, a world leader in the field of Stem Cells and Aging Studies. Marco Quarta is authors of several scientific publications in top tier journals (such as Nature, Nature Biotechnology, Cell Stem Cell, Nature Communications), and he is an inventor on U.S. patents.
Visit website: https://www.rubedolife.com/marco-quarta/
See also: Rubedo Life Sciences - Extending Health Span and Reverting Age-Related Diseases.
Details last updated 09-Sep-2020
31-May-2023 to 02-Jun-2023
Event about aging and aging related diseases organized by Hanson Wade
29-Aug-2022 to 02-Sep-2022
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
28-Aug-2023 to 01-Sep-2023
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
17-Feb-2022
Online webinar by Cambridge University Longevity Society with Marco Quarta, Co-Founder & CEO of Rubedo Life Sciences as speaker
29-Nov-2023 to 30-Nov-2023
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
10-May-2024 to 11-May-2024
The leading networking event for rejuvenation startups, longevity investors and translational researchers by Forever Healthy Foundation
Key points from 20 presentations from world-leading researchers
A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Another reminder of the amount of research, with multiple approaches, about to go into clinical trials
Connecting aspiring longevity founders with mentors to drive innovation in anti-ageing biotech
More and more companies making greater and greater progress - 2021 could be an exciting year
Their work will be critical amidst the COVID-19 pandemic - to move into clinical trials soon